<DOC>
	<DOCNO>NCT02100904</DOCNO>
	<brief_summary>The ULTRA Registry nationwide observational arm ULTRA trial . Data ULTRA Registry use evaluate long-term safety efficacy laparoscopic RF ablation ( Acessa ) . The ULTRA Registry recruit woman age 21 old plan undergo undergone laparoscopic RF ablation ( Acessa ) within United States . Participants recruit study material distribute clinical office across country gynecologist perform laparoscopic RF ablation ( Acessa ) . Study participant consent participate 3 year prospective study conduct UCSF laparoscopic RF ablation ( Acessa ) surgery perform study participant ' gynecologist . We evaluate change fibroid-related symptom pre-treatment value 6 , 12 , 18 , 24 , 30 , 36 month RFA ( Acessa ) . We determine long-term efficacy RFA ( Acessa ) evaluate rate re-treatment symptomatic fibroid RFA ( Acessa ) procedure . Participants ask permission review medical record assess surgical pregnancy outcome . The gynecologist perform laparoscopic RF ablation ( Acessa ) surgery ask consent complete brief study questionnaire information demographic , work history , professional training , practice setting . UC San Francisco oversight scientific administrative aspect study . All study data store securely HIPAA compliant , secure database monitor UC San Francisco Coordinating Center .</brief_summary>
	<brief_title>Uterine Leiomyoma Treatment With Radiofrequency Ablation ( ULTRA ) Registry</brief_title>
	<detailed_description />
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>Planning undergo undergone RF ablation ( Acessa ) treatment uterine fibroid . Able give inform consent &lt; 21 year age</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Fibroids</keyword>
	<keyword>Radiofrequency ablation</keyword>
</DOC>